Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia.
A possible association between the impairment of urinary concentrating ability and an impairment of the vasopressin-dependent cyclic AMP system in hypercalcemia was investigated in rat kidneys both in vivo and in vitro. The increases of urinary osmolality and negative free water clearance and the increase of urinary cyclic AMP excretion by vasopressin injection were significantly less in the hypercalcemic rats than in the control rats. The increase of cyclic AMP concentration by vasopressin in renal medullary tissue was significantly less in the slices obtained from the hypercalcem'c rats than in those obtained from the control rats. The activation of adenylate cyclase by vasopressin was significantly less in the group with an increased concentration of calcium in media than the control group, but phosphodiesterase activity was not affected by calcium concentration in the media. These data suggest that the impaired urinary concentrating ability in hypercalcemic kidneys is due at least in part to the direct inhibitory effect of calcium on the vasopressin-dependent cyclic AMP system at the level of adenylate cyclase in renal medulla.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002122:Calcium Chloride; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism*; D006934:Hypercalcemia / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology* / Q000652:urine; D066298:In Vitro Techniques; D007671:Kidney Concentrating Ability / Q000187:drug effects*; D007679:Kidney Medulla / Q000032:analysis / Q000201:enzymology; D008297:Male; D009994:Osmolar Concentration; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D051381:Rats; D014667:Vasopressins / Q000494:pharmacology*
D014667:Vasopressins; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D002122:Calcium Chloride; D002118:Calcium